Prevents hair loss and promotes new hair growth. [1]
A medicinal product intended for use on the scalp in cases of androgenetic alopecia in women and men aged 18 to 65 years. [2]
Ingredients
Minoksydyl
- Active ingredient that stimulates hair growth
- Reduces hair loss
Product description
DX2LEK max is a skin spray solution intended for the treatment of androgenic alopecia in women and men aged 18 to 65. Its active ingredient, minoxidil, stimulates hair growth and inhibits hair loss [3]. The medicinal product works by stimulating hair follicles and prolonging the hair growth cycle. DX2LEK max is a medicinal product intended for women and men aged 18 to 65 who suffer from hair thinning caused by androgenetic alopecia.
[1] According to section 5.1 of the SPC: Minoxidil stimulates hair growth in androgenetic alopecia. It reverses or inhibits the miniaturisation of hair follicles and has a strong stimulating effect on the proliferation of follicular cells in the growth phase. The mechanism of action of minoxidil is not fully understood.
[2] In accordance with section 4.1 of the SPC
[3] According to section 5.1 of the SPC, minoxidil stimulates hair growth in androgenetic alopecia. It reverses or inhibits the miniaturisation of hair follicles and has a strong stimulating effect on the proliferation of follicular cells in the growth phase. The mechanism of action of minoxidil is not fully understood.
The medicinal product should be applied topically to the scalp.
The product is intended for use in women and men aged 18 to 65.
The product should be used in accordance with the instructions in the package leaflet. Do not exceed the recommended dose. Wash your hands after using the product.
If no improvement is seen after two months of use, discontinue treatment. The maximum therapeutic effect is achieved after approximately 12 months of use.
60 mL (minimum 240 doses)
- Use only on healthy, undamaged scalp.
- The product is for external use only - do not use on other parts of the body.
- Avoid contact with eyes and mucous membranes; in case of contact, rinse thoroughly with water.
- Do not inhale mist/vapours. Wash hands after use.
- Do not use higher doses or more frequently than recommended - this will not accelerate the effect.
- The medicinal product contains alcohol, which may irritate the mucous membranes and eyes.
- At the beginning of treatment, temporary increased hair loss may occur; if it persists for more than 2 weeks, discontinue use and consult your doctor.
- Use with caution in patients with cardiovascular disease or heart rhythm disorders (medical consultation recommended).
- In case of chest pain, rapid heartbeat, fainting/dizziness, swelling or sudden weight gain, discontinue use and contact your doctor.
- Keep out of reach of children; avoid contact with application sites.
- Flammable product – do not use near fire, lit cigarettes or while using a hairdryer.
Store below 25°C. Store in the original packaging to protect from light. Do not refrigerate or freeze.
- Hypersensitivity to the active substance (minoxidil) or to any of the excipients.
- Hypertension (in treated and untreated patients)
- Sudden or unexplained hair loss
- Hair loss associated with serious diseases (e.g. thyroid dysfunction, systemic lupus erythematosus) or hair loss from a specific area of the skin due to inflammation of the scalp or other diseases.
- Use on shaved or diseased scalp (e.g. psoriasis, inflammation; red, irritated or painful scalp).
- Use under occlusive dressings or simultaneous topical use of other medicinal products.
Androgenetic alopecia
Androgenetic alopecia is the most common form of hair loss, occurring in both men and women. It is progressive in nature and manifests itself in gradual hair thinning and miniaturisation of hair follicles. In men, it typically affects the temporal-frontal area and the top of the head, while in women it most often affects the crown of the head. The underlying causes of the condition are multifactorial and include genetic factors and the influence of androgens [1].
Possible causes of the problem:
Hormonal changes, genetic factors, stress, and micronutrient deficiencies [2].
[1] Oiwoh SO, Enitan AO, Adegbosin OT, Akinboro AO, Onayemi EO. Androgenetic alopecia: A review. Niger Postgrad Med J. 2024;31(2):85–92
[2] Oiwoh SO, Enitan AO, Adegbosin OT, Akinboro AO, Onayemi EO. Androgenetic alopecia: A review. Niger Postgrad Med J. 2024;31(2):85–92
See other products
View all products
DX2 Shampoo
Young Men
DX2 Shampoo
For grey hair with purple pigment
Skin spray, solution
DX2LEK MAX
DX2 Shampoo
Against hair loss
DX2 shampoo
Against greying hair
DX2 Shampoo
Against dandruff and hair loss
DX2 Shampoo
Against greasy hair and hair loss
DX2 Shampoo
Deep cleansing with activated charcoal
DX2LEK, 20 mg/ml, płyn na skórę. 1 ml płynu zawiera 20 mg minoksydylu (Minoxidilum). Wskazania: Produkt leczniczy DX2LEK jest wskazany w leczeniu łysienia typu męskiego (alopecia androgenetica) u mężczyzn i u kobiet w wieku od 18 do 65 lat. DX2LEK jest najbardziej skuteczny u ludzi młodszych we wczesnych fazach procesu łysienia. Lepsze wyniki leczenia uzyskuje się w okolicy szczytu głowy niż w części czołowo-skroniowej. Zaprzestanie leczenia powoduje cofanie się efektu leczniczego w ciągu kilku miesięcy. Podmiot odpowiedzialny: Aflofarm Farmacja Polska Sp. z o.o.
To jest lek. Dla bezpieczeństwa stosuj go zgodnie z ulotką dołączoną do opakowania. Nie przekraczaj maksymalnej dawki leku. W przypadku wątpliwości skonsultuj się z lekarzem lub farmaceutą.